Terms: = Uterine cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270 AND Treatment
3 results:
1. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
[TBL] [Abstract] [Full Text] [Related]
2. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
Ge F; Tie W; Zhang J; Zhu Y; Fan Y
J Clin Lab Anal; 2021 Nov; 35(11):e24015. PubMed ID: 34606634
[TBL] [Abstract] [Full Text] [Related]
3. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
Awunor O; Berger D; Kirisits C
Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
[TBL] [Abstract] [Full Text] [Related]
